1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 24 AUGUST 2015

Cancer Drug News 24 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Intensifying Early Access Climate Requires Companies To Be Proactive
Industry Brief - PharmaMar/STA Sign Aplidin Licensing Deal In Australia/New Zealand
Industry Brief - BioLineRx Initiates BL-8040 Phase IIb Trial In AML
Industry Brief - Adcetris Receives Regular FDA Approval For Classical HL Following HSCT
Industry Trend Analysis - Velcade Successor Will Face Tougher Market Environment
Industry Brief - Syndax Raises Funds To Support Entinostat Development
Industry Brief - MTG-201 Gains FDA ODD For Malignant Mesothelioma
Industry Brief - CHMP Issues Positive Opinion On Giotrif Label Update
Industry Brief - Telesta Therapeutics Closes USD28.6mn Private Placement
Industry Brief - Dosing Begins In MVI-816/Keytruda Combination Trial For PCA
Industry Brief - Spectrum/FDA Reach SPA Agreement On Apaziquone Phase III Trial In NMIBC
Industry Brief - Axalimogene Filolisbac/Durvalumab Combination Trial Begins In HPV-Associated Cancers
Industry Brief - FDA Grants Breakthrough Therapy Designation To Exelixis' Cabozantinib For Advanced RCC
Industry Brief - Dosing Begins In VBL's VB-111 Phase III Trial In rGBM
Industry Brief - Orbus Raises Funds To Advance Eflornithine In Recurrent Anaplastic Astrocytoma
Industry Trend Analysis - Limited Options Create Favourable Market Environment For Novartis' Odomzo
Industry Brief - FDA Grants Priority Review For Keytruda In First-Line Advanced Melanoma
Industry Brief - NMT Pharma/CAO Pharma Sign CZ-48 Worldwide Licensing Deal
Industry Brief - AstraZeneca/Peregrine Enter Immuno-Oncology Trial Collaboration
Industry Trend Analysis - Liquid Biopsy/Genomic Data Combination Will Improve Drug Development
Industry Brief - R-Pharm Acquires Ixempra From BMS; Launches US Commercial Operations
Industry Brief - Cancer Conferences - October 2015

Table Of Contents

Cancer Drug News 24 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.